Skip to content

AstroNova, Inc. ALOT Grant Deferred Revenue Non Current

Grant Deferred Revenue Non Current at other companies

Ameresco logo
AmerescoAMRC
$5.19M-8.3%
Sunrun logo
SunrunRUN
$194.1M+0.6%
Hyperfine, Inc. logo
Hyperfine, Inc.HYPR
$500K+13.4%
ICU Medical logo
ICU MedicalICUI
-$505K+0.8%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$2.36M+93.1%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$15K-97.7%

Other financials

Income statement

See full
Revenue$39.4M+4.4%
Gross profit$14.4M+20.7%
Operating income$1.6M+174%
Net income$653.0K+274%
EPS (diluted)$0.08+260%

Balance sheet

See full
Cash & equivalents$4.7M-12.7%
Total debt$22.9M-1.3%
Total equity$77.5M+1.3%
Total assets$139.9M-7.0%

Cash flow

See full
Operating cash flow$3.0M-31.3%
CapEx$36.0K-40.0%
Free cash flow$3.0M-31.1%

Valuation

See full
Market cap$221.25M+214%
Enterprise value$239.45M+171%
P/S1.5×+1.0×

Profitability

See full
Gross margin32.5%0.0pp
Operating margin1.4%+0.8pp
Net margin-0.9%-0.4pp
FCF margin6.6%

Returns & leverage

See full
Return on equity-1.7%-0.8pp
Debt / equity0.3×0.0×
Current ratio1.8×+0.1×

Where this comes from

Reported directly by AstroNova, Inc. in its filing.

Tagged under the XBRL concept alot:GrantDeferredRevenueNonCurrent.

The official record: AstroNova, Inc.’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AstroNova, Inc.'s grant deferred revenue non current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AstroNova, Inc.'s grant deferred revenue non current?
AstroNova, Inc. (ALOT) reported grant deferred revenue non current of $926K in Q1 2026.
How has AstroNova, Inc.'s grant deferred revenue non current changed year-over-year?
AstroNova, Inc.'s grant deferred revenue non current decreased by 19.1% year-over-year, from $1.14M to $926K.
What does grant deferred revenue non current mean?
This represents the portion of government or private research grants received in advance that will be recognized as revenue beyond the next fiscal year. It signifies the company's success in securing external funding for long-term development projects or innovation initiatives. This balance serves as a forward-looking indicator of future revenue streams tied to specific project milestones.